Cecilie U. Rank
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Central nervous system penetration of imatinib in acute lymphoblastic leukemia: Pharmacokinetic analysis and clinical implications.
Journal: Cancer chemotherapy and pharmacology
Published: March 27, 2026
Pharmacokinetic profiling of imatinib in relation to CYP3A4 activity in leukaemia patients.
Journal: British journal of clinical pharmacology
Published: September 30, 2025
Therapeutic drug monitoring in acute lymphoblastic leukemia-a deep dive into pharmacokinetics, -dynamics, and -genetics of antileukemic drugs.
Journal: Expert review of clinical pharmacology
Published: February 14, 2025
Recognition, prevention, and management of adverse events associated with asparaginase/ pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of an expert panel.
Journal: Haematologica
Published: December 14, 2024
Therapeutic drug monitoring of imatinib - how far are we in the leukemia setting?
Journal: Expert review of clinical pharmacology
Published: February 12, 2024
Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis: A part of the ALL-STAR study.
Journal: European journal of haematology
Published: December 15, 2023
PEG-asparaginase treatment regimens for acute lymphoblastic leukaemia in children: a network meta-analysis.
Journal: The Cochrane database of systematic reviews
Published: June 01, 2023
Cerebral sinovenous thrombosis and asparaginase re-exposure in patients aged 1-45 years with acute lymphoblastic leukaemia: A NOPHO ALL2008 study.
Journal: EJHaem
Published: March 28, 2022
Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based study.
Journal: Leukemia & lymphoma
Published: October 21, 2021
Last Updated: 09/26/2026